Legler J,Van den Brink C E,Brouwer A,et al. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line[J]. Toxicological Sciences,1999,48:55-66
[6]
Meerts I A, Letcher R J, Hoving S, et al. In vitro estrogenicity of polybrominateddiphenylethers, hydroxylated PDBEs, and polybrominated bisphenol A compounds[J]. Environmental Health Perspectives,2001,109: 399-407
[7]
Hamers T, Kamstra J H, Sonneveld E, et al. In vitro profiling of the endocrine-disrupting potency of brominated flame retardants[J]. Toxicological Sciences, 2006, 92: 157-173
[8]
Mercado-Feliciano M, Bigsby R M. Hydroxylated metabolites of the polybrominateddiphenyl ether mixture DE-71 are weak estrogen receptor-a ligands[J]. Environmental Health Perspectives, 2008,116: 1315-1321
[9]
Kojima H, Takeuchi S, Uramaru N, et al. Nuclear hormone receptor activity of polybrominated diphenyl ethers and their hydroxylated and methoxylated metabolites in transactivation assays using Chinese hamster ovary cells[J]. Environmental Health Perspectives, 2009,117: 1210-1218
[10]
Kitamura S, Shinohara S, Iwase E, et al. Affinity for thyroid hormone and estrogen receptors of hydroxylated polybrominated diphenyl ethers[J]. Journal of Health Science, 2008, 54(5):607-614
[11]
Cantón R F, Sanderson J T, Letcher R J, et al. Inhibition and induction of aromatase (CYP19)activity by brominated flame retardants in H295R human adrenocortical carcinoma cells[J]. Toxicological Sciences, 2005, 88(2): 447-455
[12]
Cantón R F, Scholten D E A, Marsh G, et al. Inhibition of human placental aromatase activity by hydroxylated polybrominated diphenyl ethers(OH-PBDEs)[J].Toxicology and Applied Pharmacology, 2008, 227(1): 68-75
Holger G,Gerhard K. DrugScore meets CoMFA: Adaptation of fields for molecular comparison(AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein[J].Journal of Medicinal Chemistry,2002, 45: 4153-4170
[17]
Ewing T J A, Makino S, Skillman A G, et al. DOCK 4.0: Research strategies for automated molecular docking of flexible molecule database[J]. Journal of Computer-Aided Molecular Design, 2001, 15 (5):411-428
[18]
Sanderson J T,Hordijk J, Denison M S, et al. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells[J]. Toxicological Sciences,2004, 82: 70-79
